GlassScriptPhysician profile
Inyong Hwang
NPI 1528346111
$4,931.73
in general payments reported to CMS, 2019-2025
31 companies · $888 in 2025
The $888 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $807 · 2020: $19.77 · 2021: $409 · 2022: $608 · 2023: $1,299 · 2024: $901 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,068 · Education: $19.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,067.82 |
| Education | $19.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $896.72 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $534.35 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $490.78 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $343.71 | 2021-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $283.04 | 2019-2023 | Assurity, Gallant |
| Pfizer INC. | $239.46 | 2019-2025 | |
| Boston Scientific Corporation | $199.07 | 2024 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack |
| Lexicon Pharmaceuticals, INC. | $198.08 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.42 | 2024-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $133.79 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.50 | 2022-2025 | Lifevest |
| Irhythm Technologies, INC. | $124.17 | 2021-2023 | Zio Xt Patch |
| Esperion Therapeutics, INC. | $108.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $102.61 | 2019-2022 | |
| Radius Health, INC. | $101.48 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $98.22 | 2023 | Da Vinci Surgical System |
| Baxter Healthcare | $97.91 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Medtronic Vascular, INC. | $94.96 | 2019 | |
| Angiodynamics, INC. | $91.67 | 2023 | Auryon Laser System 100-120 Vac |
| Lilly USA, LLC | $90.15 | 2022 | |
| Ibsa Pharma INC. | $68.05 | 2023 | Licart |
| Heartflow, INC. | $57.91 | 2022-2025 | |
| Gilead Sciences, INC. | $50.62 | 2019 | |
| Janssen Pharmaceuticals, INC | $39.43 | 2019-2021 | |
| Medtronic, INC. | $38.17 | 2023-2024 | Venaseal |
| Phathom Pharmaceuticals, INC. | $28.98 | 2025 | Voquezna |
| Aimmune Therapeutics, INC. | $28.08 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $27.50 | 2024 | Arcalyst |
| Edwards Lifesciences Corporation | $21.73 | 2022 | |
| Glaxosmithkline, LLC. | $19.92 | 2025 | Shingrix |
| Tactile Systems Technology INC | $11.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inyong Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.